Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001193125-26-140164

Options or other derivatives

  • Chief Executive Officer acquired 600,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mohindru Mani Chief Executive Officer 2026-03-31 Grant or award · Stock Options +600,000 968,766 D: show line 1 in the form
Loading xslF345X06/ownership.xml…